Zacks Investment Ideas feature highlights: CyberArk, Lam Research and monday.com

29.05.25 11:19 Uhr

Werte in diesem Artikel
Aktien

73,66 EUR -0,95 EUR -1,27%

Indizes

21.364,0 PKT 45,8 PKT 0,21%

19.175,9 PKT 74,9 PKT 0,39%

1.854,4 PKT -8,4 PKT -0,45%

5.912,2 PKT 23,6 PKT 0,40%

For Immediate ReleaseChicago, IL – May 29, 2025 – Today, Zacks Investment Ideas feature highlights CyberArk Software Ltd. CYBR, Lam Research Corp. LRCX and monday.com Ltd. MNDY.3 Nasdaq-Listed Tech Stocks Flying High in 2025 Signaling More UpsideU.S. stock markets have suffered a setback in 2025 after the artificial intelligence (AI)-driven astonishing bull run of 2023 and 2024. The highly overstretched valuation of U.S. stocks, sticky inflation, several weak economic data, geopolitical conflicts and severe concerns related to the Trump administration’s tariff and trade policies have significantly dented market participants confidence in risky assets like equities.The technology sector has suffered the most since these stocks, especially the AI-focused ones, have skyrocketed in the last two years. The Fed’s ambiguity over further rate cuts in 2025, concerns of a near-term recession and the availability of a low-cost Chinese AI platform have unnerved investors.Consequently, the tech-heavy Nasdaq Composite is down 0.4% year to date. Nevertheless, a handful of Nasdaq Composite-listed technology stocks with a favorable Zacks Rank has provided double-digit returns year to date.We have selected three such stocks that have the potential to provide double-digit returns from their current price level in the near future. These stocks are: CyberArk Software Ltd., Lam Research Corp. and monday.com Ltd.Each of our picks currently carries either a Zacks Rank #1 (Strong Buy) or 2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.CyberArk Software Ltd.Zacks Rank #1 CyberArk Software is benefiting from the rising demand for cybersecurity and privileged access security solutions due to the long list of data breaches and increasing digital transformation strategies.A strong presence across verticals, such as banking, healthcare, government and utilities, is safeguarding CYBR from the adverse effects of softening IT spending. CYBR’s strategic mix shift toward software-as-a-service and subscription-based solutions is driving top-line growth.CyberArk is gaining customer accounts, which contributes to its revenues. The vast customer base presents the company with an opportunity to upsell products within its installed user base. Furthermore, in the last few quarters, CYBR has been able to close a significant number of seven-figure deals.The growing number of large deals in the revenue mix is a positive as it increases deferred revenues and visibility. Moreover, any product refresh brings in additional dollars as every enterprise attempts to keep its threat management infrastructure updated. These factors in turn support CYBR’s top line.CyberArk Software has an expected revenue and earnings growth rate of 31.9% and 25.1%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 3.6% in the last 30 days.The short-term average price target of brokerage firms for the stock represents an increase of 16.6% from the last closing price of $382.81. The brokerage target price is currently in the range of $380-$500. This indicates a maximum upside of 30.6% and almost no downside.Lam Research Corp.Zacks Rank #2 Lam Research is riding on its strength across 3D DRAM and advanced packaging technologies. Growing etch and deposition intensity owing to increasing technology inflections in 3D architectures is a plus. A rebound in the System business owing to improving memory spending is a positive for LRCX.Strategic investments in research and development activities position LRCX well to capitalize on the growing wafer fab equipment (WFE) spending. For 2025, WFE is expected to be approximately $100 billion. Foundry/logic, DRAM and NAND investments are expected to be higher year over year. Solid demand related to LRCX’s high-bandwidth memory is another driver.Lam Research has an expected revenue and earnings growth rate of 22.2% and 33.4%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.5% in the last 30 days.The short-term average price target of brokerage firms for the stock represents an increase of 12.4% from the last closing price of $83.94. The brokerage target price is currently in the range of $70-$125. This indicates a maximum upside of 48.8% and a downside of 16.7%.monday.com Ltd. Zacks Rank #1 monday.com develops software applications in the United States, Europe, the Middle East, Africa, and internationally. MNDY provides Work OS, a cloud-based visual work operating system that consists of modular building blocks used and assembled to create software applications and work management tools.MNDY also offers product solutions for work management, sales CRM, software development verticals, business development, presale, and customer success services. MNDY serves organizations, educational or government institutions, and distinct business units of an organization.monday.com has an expected revenue and earnings growth rate of 25.6% and 6.3%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 12% in the last 30 days.The short-term average price target of brokerage firms for the stock represents an increase of 21.3% from the last closing price of $299.11. The brokerage target price is currently in the range of $280-$450. This indicates a maximum upside of 50.5% and a downside of 6.4%.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lam Research Corporation (LRCX): Free Stock Analysis Report CyberArk Software Ltd. (CYBR): Free Stock Analysis Report monday.com Ltd. (MNDY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Lam Research und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Lam Research

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Lam Research

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Lam Research Corp.

Wer­bung

Analysen zu Lam Research Corp.

DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
29.10.2018Lam Research NeutralB. Riley FBR
DatumRatingAnalyst
25.04.2019Lam Research OutperformCowen and Company, LLC
22.04.2019Lam Research BuyB. Riley FBR
24.01.2019Lam Research OutperformCowen and Company, LLC
21.12.2018Lam Research BuyNeedham & Company, LLC
17.10.2018Lam Research OutperformCowen and Company, LLC
DatumRatingAnalyst
29.10.2018Lam Research NeutralB. Riley FBR
01.10.2018Lam Research HoldDeutsche Bank AG
01.10.2018Lam Research NeutralMizuho
12.10.2016Lam Research Sector WeightPacific Crest Securities Inc.
21.04.2015Lam Research Sector PerformRBC Capital Markets
DatumRatingAnalyst
22.10.2015Lam Research UnderperformRBC Capital Markets
05.10.2015Lam Research UnderperformRBC Capital Markets
11.11.2010Lam Research sellCitigroup Corp.
29.07.2010Lam Research sellCitigroup Corp.
19.03.2009Lam Research underperformCredit Suisse Group

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Lam Research Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen